methyldopa has been researched along with procainamide in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (53.13) | 18.7374 |
1990's | 1 (3.13) | 18.2507 |
2000's | 8 (25.00) | 29.6817 |
2010's | 6 (18.75) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Drayer, DE | 1 |
Maas, D; Schubothe, H | 1 |
Kumar, KL; Reuler, JB | 1 |
Tabor, PA | 1 |
Cush, JJ; Goldings, EA | 1 |
Estes, D; Peltier, AP | 1 |
Almeyda, J; Levantine, A | 1 |
Eldredge, NT; Jiller, JJ; van Robertson, WB | 1 |
Davies, NE; Harrison, CE | 1 |
de Sèze, S; Dorfmann, H; Kahn, MF | 1 |
Feltkamp, TE; ten Veen, JH | 1 |
ten Veen, JH | 1 |
DeSwarte, RD | 1 |
Holborow, EJ | 1 |
Parker, CW | 1 |
Greenblatt, DJ; Lloyd, BL | 1 |
Arndt, P; Garratty, G; Prince, HE; Shulman, IA | 1 |
Rouger, P; Wautier, JL | 1 |
Terada, H | 1 |
7 review(s) available for methyldopa and procainamide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug-induced fever.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Body Temperature Regulation; Drug Hypersensitivity; Fever; Humans; Methyldopa; Phenytoin; Procainamide; Quinidine | 1986 |
Drug-induced lupus: clinical spectrum and pathogenesis.
Topics: Acetylation; Adult; Aged; Antibodies, Antinuclear; Antibody Specificity; Autoimmune Diseases; Black People; Brain; Chlorpromazine; Female; Heart; Humans; Hydralazine; Isoniazid; Kidney; Liver; Lung; Lupus Erythematosus, Systemic; Male; Methyldopa; Muscles; Phenotype; Procainamide | 1985 |
Antinuclear antibodies.
Topics: Animals; Antibodies, Antinuclear; Antibody Formation; Arthritis, Rheumatoid; Autoantigens; Cytotoxicity Tests, Immunologic; DNA; Fluorescent Antibody Technique; Humans; Hydralazine; Immune Adherence Reaction; Isoniazid; Lupus Erythematosus, Systemic; Methyldopa; Nephritis; Neutrophils; Nucleoproteins; Procainamide; Sjogren's Syndrome | 1972 |
Cutaneous reactions to cardiovascular drugs.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Clonidine; Debrisoquin; Digitalis Glycosides; Drug Eruptions; Ethacrynic Acid; Furosemide; Guanethidine; Humans; Hydralazine; Mercury; Methyldopa; Nitroglycerin; Pentaerythritol Tetranitrate; Procainamide; Quinidine; Thiazines | 1973 |
[Drug-induced hemolytic anemia].
Topics: Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Cephalosporins; Cyclosporine; Hemolytic-Uremic Syndrome; Humans; Isoantibodies; Leukemia, Lymphocytic, Chronic, B-Cell; Methyldopa; Procainamide; Purpura, Thrombocytopenic; Quinine; Rho(D) Immune Globulin; Thrombocytopenia; Vidarabine | 2001 |
[Drug-induced hemolytic anemia].
Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Antigen-Antibody Complex; Antiviral Agents; Autoantibodies; Diagnosis, Differential; Glucosephosphate Dehydrogenase Deficiency; Haptens; Hemolytic-Uremic Syndrome; Humans; Methyldopa; Penicillins; Procainamide; Proton Pump Inhibitors; Purpura, Thrombotic Thrombocytopenic; Quinidine; Ribavirin | 2007 |
25 other study(ies) available for methyldopa and procainamide
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Active drug metabolites and renal failure.
Topics: Acetylation; Biotransformation; Clofibrate; Humans; Kidney Failure, Chronic; Meperidine; Methyldopa; Nitrofurantoin; Oxypurinol; Pharmaceutical Preparations; Procainamide; Sulfonamides | 1977 |
[Drug-induced systemic lupus erythematosus (author's transl)].
Topics: Adolescent; Aged; Anti-Bacterial Agents; Antibody Formation; Autoantibodies; Child; Chlorpromazine; Female; Humans; Hydralazine; Immune Tolerance; Lupus Erythematosus, Systemic; Methyldopa; Practolol; Procainamide | 1977 |
Drug fever.
Topics: Anesthesia, Inhalation; Anti-Bacterial Agents; Antidepressive Agents, Tricyclic; Antineoplastic Agents; Drug-Related Side Effects and Adverse Reactions; Epinephrine; Fever; Humans; Malignant Hyperthermia; Methyldopa; Monoamine Oxidase Inhibitors; Muscle Relaxants, Central; Norepinephrine; Parasympatholytics; Phenothiazines; Procainamide; Procaine; Vaccines | 1975 |
Drug fever.
Topics: Allopurinol; Anti-Bacterial Agents; Body Temperature Regulation; Drug Hypersensitivity; Fever; Humans; Interleukin-1; Isoniazid; Methyldopa; Phenytoin; Procainamide; Quinidine | 1986 |
The interaction of lupus-inducing drugs with deoxyribonucleic acid.
Topics: Adult; Animals; Cattle; Child; DNA; DNA, Single-Stranded; Hot Temperature; Humans; Hydralazine; Immunodiffusion; Isoniazid; Lupus Erythematosus, Systemic; Methyldopa; Nucleic Acid Conformation; Nucleic Acid Denaturation; Optical Rotation; Oxazoles; Phenytoin; Procainamide; Propylthiouracil; Thymus Gland; Trimethadione; Viscosity | 1974 |
Unusual reactions to common cardiovascular drugs.
Topics: Aged; Cardiovascular Diseases; Digitalis Glycosides; Drug Eruptions; Drug Hypersensitivity; Female; Gynecomastia; Humans; Male; Methyldopa; Middle Aged; Procainamide; Purpura; Quinidine | 1970 |
[Iatrogenic lupus: current status of the question. I. Clinical study and main drugs responsible].
Topics: Antibodies, Antinuclear; Contraceptives, Oral; Diagnosis, Differential; Humans; Hydralazine; Iatrogenic Disease; Isoniazid; Lupus Erythematosus, Systemic; Methyldopa; Procainamide; Sulfonamides | 1972 |
Studies on drug induced lupus erythematosus in mice. I. Drug induced antinuclear antibodies (ANA).
Topics: Administration, Oral; Animals; Antibodies, Antinuclear; Antibody Formation; Chlorthalidone; Coombs Test; DNA; Female; Fluorescent Antibody Technique; Genetics; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Male; Methyldopa; Mice; Mice, Inbred Strains; Procainamide; Sex Factors | 1972 |
Studies on drug-induced lupus erythematosus in mice. II. Drug-induced smooth muscle and skeletal muscle antibodies.
Topics: Animals; Antibody Formation; Autoantibodies; Cell Membrane; Chlorthalidone; Fluorescent Antibody Technique; Hydralazine; Isoniazid; Liver; Lupus Erythematosus, Systemic; Lymphocytes; Methyldopa; Mice; Mice, Inbred A; Mice, Inbred BALB C; Mice, Inbred C57BL; Muscle, Smooth; Muscles; Procainamide | 1973 |
Drug allergy--problems and strategies.
Topics: Anaphylaxis; Anemia, Hemolytic; Antigen-Antibody Complex; Desensitization, Immunologic; Dose-Response Relationship, Immunologic; Drug Hypersensitivity; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Encephalomyelitis, Acute Disseminated; Exanthema; Humans; Hydralazine; Immunity, Cellular; Isoniazid; Kidney Diseases; Liver Diseases; Lupus Erythematosus, Systemic; Lymphoid Tissue; Methyldopa; Nephritis, Interstitial; Penicillins; Phenytoin; Procainamide; Respiratory Hypersensitivity; Vasculitis, Leukocytoclastic, Cutaneous | 1984 |
Drug effects on autoantibodies and immune complexes.
Topics: Acetylation; Antibodies, Antinuclear; Antigen-Antibody Complex; Arthritis, Rheumatoid; Autoantibodies; Autoimmune Diseases; Binding Sites; Complement C1; Humans; Hydralazine; Immunoglobulin M; Lupus Erythematosus, Systemic; Methyldopa; Penicillamine; Procainamide; Rheumatoid Factor | 1980 |
Hapten immunology and allergic reactions in humans.
Topics: Animals; Autoimmune Diseases; Carrier Proteins; Drug Hypersensitivity; Environmental Health; Haptens; HLA Antigens; Humans; Hydralazine; Immunization, Passive; Isoniazid; Lupus Erythematosus, Systemic; Macromolecular Substances; Methyldopa; Nitrobenzenes; Nucleic Acids; Penicillins; Procainamide | 1981 |
Neuropsychiatric sequelae of pharmacotherapy of cardiac arrhythmias and hypertension.
Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Brain; Drug Interactions; Guanethidine; Humans; Hydralazine; Hypertension; Lidocaine; Methyldopa; Procainamide; Psychotropic Drugs; Quinidine; Seizures | 1981 |
The effect of methyldopa and procainamide on suppressor cell activity in relation to red cell autoantibody production.
Topics: Autoantibodies; Blood Group Antigens; Cell Division; Cells, Cultured; Coombs Test; Humans; Immunoglobulin G; Leukocytes, Mononuclear; Methyldopa; Procainamide; T-Lymphocytes, Regulatory | 1993 |